Dominant V beta 8 gene usage in response to TNP: failure to use other V beta chains following removal of V beta 8+ T cells by monoclonal antibody in vivo
- PMID: 8045598
- PMCID: PMC1414846
Dominant V beta 8 gene usage in response to TNP: failure to use other V beta chains following removal of V beta 8+ T cells by monoclonal antibody in vivo
Abstract
This paper investigates the V beta usage of lymph node cells from mice immunized with TNP and of cell lines made from them. In cell lines stimulated weekly with TNP in vitro for 1 month, about 87% of the cells were V beta 8+ and further analysis showed that these cells were actually V beta 8.2+. This was also true for the cells that proliferated in lymph nodes in response to TNP 4 days after primary immunization, i.e. proliferation occurred mainly in the V beta 8+, and in particular in the V beta 8.2+, population while much less proliferation occurred when the V beta 8- or V beta 8.2- T-cell populations are used. This was not due to non-specific damage during separation, as the response to concanavalin A and alloantigen was intact. In a separate series of experiments, mice were acutely depleted of V beta 8+ T cells by treatment with F23.1 or a control monoclonal antibody (mAb) in vivo given before immunization. Treatment with the relevant mAb virtually abolished the response to TNP. In contrast, SJL mice, which lack the gene segment coding for the V beta 8 family and several other V beta chains, made a normal proliferative and delayed-type hypersensitivity (DTH) response to TNP. This poses the problem, which may be important in the study of the T-cell repertoire, of why acute removal of V beta 8+ T cells, which are dominantly used in the response to TNP, does not allow T cells using other chains to substitute in the response, while the absence of this population over a long period of time, because of a deletion in the genome, allows the use of T cells bearing other V beta chains.
Similar articles
-
Predominant T cell receptor gene elements in TNP-specific cytotoxic T cells.J Immunol. 1991 Oct 15;147(8):2467-73. J Immunol. 1991. PMID: 1840614
-
Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis (MAM). VIII. Selective activation of T cells expressing distinct V beta T cell receptors from various strains of mice by the "superantigen" MAM.J Immunol. 1990 Jan 15;144(2):425-31. J Immunol. 1990. PMID: 2136890
-
Major histocompatibility complex control of the class of the immune response to the hapten trinitrophenyl.Immunology. 1995 Mar;84(3):355-9. Immunology. 1995. PMID: 7751016 Free PMC article.
-
Antibody and complement modulation of tumor cell growth in vitro and in vivo.Fed Proc. 1978 Aug;37(10):2385-9. Fed Proc. 1978. PMID: 354972 Review.
-
T cell V-gene usage in man in some normal and abnormal situations.Ann N Y Acad Sci. 1991 Dec 30;636:9-19. doi: 10.1111/j.1749-6632.1991.tb33433.x. Ann N Y Acad Sci. 1991. PMID: 1793233 Review. No abstract available.
Cited by
-
The effect of cyclosporin A, FK506 and rapamycin on the murine contact sensitivity reaction.Clin Exp Immunol. 1998 Apr;112(1):112-9. doi: 10.1046/j.1365-2249.1998.00537.x. Clin Exp Immunol. 1998. PMID: 9566798 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases